Ana Maria Manso

Ana Maria Manso

Auto-generated profile, based on publicly available information

Ana Maria Manso

Division of Cardiology, Department of Medicine, UC San Diego, San Diego, CA 92037, USA

Research Focus & Metrics

Academic Career Length

27Years (2000-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
18 March 2020 in Science Translational Medicine
Verified
Journal Article
Closed access
PDF file
AMAna Maria Manso
Ana Maria Manso
SHSherin I. Hashem
Sherin I. Hashem
BNBradley C. Nelson
Bradley C. Nelson
EGEmily Gault
Emily Gault
ASAngel Soto-Hermida
Angel Soto-Hermida
EAEric Adler
Eric Adler
Danon disease (DD) is a rare X-linked autophagic vacuolar myopathy associated with multiorgan dysfunction, including the heart, skeletal muscle, and liver. There are no specific treatments, and most male patients die from advanced heart failure during the second or third decade of life. DD is caused by mutations in the lysosomal-associated membrane protein 2 (LAMP2) gene, a key mediator of autophagy. LAMP2 has three isoforms: LAMP2A, LAMP2B, and LAMP2C. LAMP2B is the predominant isoform expressed in cardiomyocytes. This study evaluates the efficacy of human LAMP2B gene transfer using a recombinant adeno-associated virus 9 carrying human LAMP2B (AAV9.LAMP2B) in a Lamp2 knockout (KO) mouse, a DD model. AAV9.LAMP2B was intravenously injected into 2- and 6-month-old Lamp2 KO male mice to assess efficacy in adolescent and adult phenotypes. Lamp2 KO mice receiving AAV9.LAMP2B demonstrated dose-dependent restoration of human LAMP2B protein in the heart, liver, and skeletal muscle tissue. Impaired autophagic flux, evidenced by increased LC3-II, was abrogated by LAMP2B gene transfer in all tissues in both cohorts. Cardiac function was also improved, and transaminases were reduced in AAV9.LAMP2B-treated KO mice, indicating favorable effects on the heart and liver. Survival was also higher in the older cohort receiving high vector doses. No anti-LAMP2 antibodies were detected in mice that received AAV9.LAMP2B. In summary, LAMP2B gene transfer improves metabolic and physiologic function in a DD murine model, suggesting that a similar therapeutic approach may be effective for treating patients with this highly morbid disease.

19 March 2019 in Circulation
Verified
Journal Article
Open access
PDF file
ZZZHIYUAN ZHANG
ZHIYUAN ZHANG
YMYongxin Mu
Yongxin Mu
JZJianlin Zhang
Jianlin Zhang
YZYangzhao Zhou
Yangzhao Zhou
PCPaola Cattaneo
Paola Cattaneo
JCJu Chen
Ju Chen

1 December 2000 in Cryobiology
Verified
Journal Article
Closed access
JRJuliana Redondo
Juliana Redondo
AMAna Maria Manso
Ana Maria Manso
MPMaria Elena Pacheco
Maria Elena Pacheco
LHLourdes Hernández
Lourdes Hernández
MSMercedes Salaices Sanchez
Mercedes Salaices Sanchez
JMJesús Marı́n
Jesús Marı́n